Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse Licenses Multiplexing, Molecular Detection Patents from Abbott

NEW YORK (GenomeWeb News) – Prodesse has licensed two patents from Abbott that cover multiplexing and molecular detection technologies, the Wisconsin-based company said yesterday.

Under the agreement, Prodesse acquired non-exclusive sub-licenses for US Patent No. 5,582,989, and US Patent No. 5,851,767.

The '989 "Caskey" patent, assigned to Baylor College of Medicine, covers molecular multiplexing and the '767 "Stanbridge" patent, assigned to the University of California, covers molecular detection of prokaryotic organisms, mostly bacteria.

Baylor and UC exclusively licensed these patents to Abbott, with the right to grant sublicenses.

Financial terms of the agreement were not released.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.